Cargando…

Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema

BACKGROUND: The kinins (primarily bradykinin, BK) represent the mediators responsible for local increase of vascular permeability in hereditary angioedema (HAE), HAE I-II associated with alterations of the SERPING1 gene and HAE with normal C1-Inhibitor function (HAE-nC1INH). Besides C1-Inhibitor fun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defendi, Federica, Charignon, Delphine, Ghannam, Arije, Baroso, Remi, Csopaki, Françoise, Allegret-Cadet, Marion, Ponard, Denise, Favier, Bertrand, Cichon, Sven, Nicolie, Brigitte, Fain, Olivier, Martin, Ludovic, Drouet, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734293/ https://www.ncbi.nlm.nih.gov/pubmed/23940538 http://dx.doi.org/10.1371/journal.pone.0070140

Ejemplares similares

Kininogen Cleavage Assay: Diagnostic Assistance for Kinin-Mediated Angioedema Conditions
por: Baroso, Rémi, et al.
Publicado: (2016)

Correction: Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
Publicado: (2014)

Bradykinin-induced angioedema in the emergency department
por: Hébert, Jacques, et al.
Publicado: (2022)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Pathophysiology of bradykinin and histamine mediated angioedema
por: Lima, Hermenio, et al.
Publicado: (2023)

Bradykinin Metabolism and Drug-Induced Angioedema
por: Smolinska, Sylwia, et al.
Publicado: (2023)

In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020)

In vitro reconstitution of kallikrein-kinin system and progress curve analysis
por: Favier, Bertrand, et al.
Publicado: (2022)

A Comprehensive Review of Bradykinin-Induced Angioedema Versus Histamine-Induced Angioedema in the Emergency Department
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
por: Riedl, Marc
Publicado: (2010)

Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2019)

Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
por: Debreczeni, Márta L., et al.
Publicado: (2021)

SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE
por: Drouet, Christian, et al.
Publicado: (2022)

Editorial: Kinin 2022 Meeting, Annecy, France
por: Schmaier, Alvin H., et al.
Publicado: (2023)

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
por: Aygören-Pürsün, Emel, et al.
Publicado: (2018)

Corrigendum: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Marcelino-Rodriguez, Itahisa, et al.
Publicado: (2020)

Commentary: Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics
por: Colobran, Roger
Publicado: (2020)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges
por: Mormile, Ilaria, et al.
Publicado: (2023)

The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Dyga, Wojciech, et al.
Publicado: (2022)

A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
por: Nunes, Lisete Rolo, et al.
Publicado: (2023)

Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema
por: Maurer, Marcus, et al.
Publicado: (2021)

Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors
por: Marceau, François, et al.
Publicado: (2019)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
por: Campos, Regis Albuquerque, et al.
Publicado: (2014)

A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients
por: Gobert, Delphine, et al.
Publicado: (2016)

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema()
por: Can, Pelin Kuteyla, et al.
Publicado: (2021)

Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers()
por: Douillard, Marie, et al.
Publicado: (2023)

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants
por: Marceau, François, et al.
Publicado: (2020)

Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study
por: Schulkes, Karlijn J G, et al.
Publicado: (2015)

Picomolar Sensitivity Analysis of Multiple Bradykinin-Related Peptides in the Blood Plasma of Patients With Hereditary Angioedema in Remission: A Pilot Study
por: Marceau, François, et al.
Publicado: (2022)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014)

Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency
por: Charest-Morin, Xavier, et al.
Publicado: (2018)

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons
por: Yi, Jiwon, et al.
Publicado: (2023)

Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018)

Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP(9α)
por: Mueller, Sylvia, et al.
Publicado: (2005)

Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report
por: Hahn, Janina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_djhvn1uc4l3306k0oho02imb7u